12 June 2025 : Clinical Research
Platelet-to-Lymphocyte Ratio as a Predictor of Atrial Fibrillation in STEMI Patients
Tingting Li BCDEF 1, Qi Zhang BCDEF 2, Xiaosong Gu BE 3, Yifei Tao AEF 4*, Jiayu Yin ABCDEF 3DOI: 10.12659/MSM.948334
Med Sci Monit 2025; 31:e948334
Table 3 Univariate logistic regression analysis for NOAF.
| β | S.E | Wald χ2 | OR (95% CI) | P | |
|---|---|---|---|---|---|
| Age | 0.011 | 0.011 | 0.871 | 1.011 (0.988~1.033) | 0.351 |
| Female | 0.282 | 0.304 | 0.86 | 1.326 (0.731~2.405) | 0.354 |
| BMI | 0.049 | 0.036 | 1.849 | 1.050 (0.979~1.127) | 0.174 |
| Heart rate | 0.018 | 0.010 | 3.586 | 1.018 (0.999~1.038) | 0.058 |
| SBP | −0.007 | 0.007 | 0.935 | 0.993 (0.979~1.007) | 0.334 |
| DBP | −0.001 | 0.010 | 0.014 | 0.999 (0.979~1.019) | 0.907 |
| Hypertension | 0.131 | 0.287 | 0.207 | 1.140 (0.649~2.001) | 0.649 |
| Diabetes | 0.254 | 0.314 | 0.654 | 1.289 (0.697~2.383) | 0.419 |
| Previous anti-arrhythmia | 0.049 | 0.382 | 0.016 | 1.050 (0.496~2.220) | 0.899 |
| Smoking | 0.188 | 0.287 | 0.429 | 1.207 (0.688~2.116) | 0.512 |
| IABP | 1.337 | 0.534 | 6.274 | 3.809 (1.338~10.845) | 0.012 |
| PLR | 0.004 | 0.001 | 15.345 | 1.004 (1.002~1.006) | <0.001 |
| WBC | 0.056 | 0.043 | 1.701 | 1.058 (0.972~1.151) | 0.192 |
| Neutrophil | 0.065 | 0.031 | 4.526 | 1.067 (1.005~1.133) | 0.033 |
| Lymphocyte | −0.607 | 0.219 | 7.712 | 0.545 (0.355~0.836) | 0.005 |
| HGB | −0.004 | 0.009 | 0.196 | 0.996 (0.980~1.013) | 0.658 |
| Platelet | 0.004 | 0.002 | 2.646 | 1.004 (0.999~1.008) | 0.104 |
| CRP | 0.088 | 0.032 | 7.43 | 1.092 (1.025~1.163) | 0.006 |
| eGFR | −0.009 | 0.007 | 1.825 | 0.991 (0.979~1.004) | 0.177 |
| TNI | 0.013 | 0.009 | 2.02 | 1.013 (0.995~1.030) | 0.155 |
| NT-proBNP | 0.509 | 0.119 | 18.432 | 1.664 (1.319~2.100) | <0.001 |
| FBG | 0.072 | 0.044 | 2.638 | 1.075 (0.985~1.173) | 0.104 |
| TC | 0.056 | 0.142 | 0.158 | 1.058 (0.801~1.397) | 0.691 |
| TG | −0.166 | 0.172 | 0.927 | 0.847 (0.604~1.188) | 0.336 |
| HDL-C | 0.22 | 0.596 | 0.136 | 1.246 (0.387~4.011) | 0.712 |
| LDL-C | 0.089 | 0.162 | 0.297 | 1.093 (0.795~1.502) | 0.586 |
| LVEF | −0.12 | 0.020 | 37.931 | 0.887 (0.853~0.921) | <0.001 |
| Killip >1 | 0.930 | 0.327 | 8.026 | 2.534 (1.334~4.815) | 0.005 |
| Number of stenotic vessels | 0.069 | 0.175 | 0.157 | 1.072 (0.760~1.511) | 0.692 |
| IRA-LAD | −0.034 | 0.287 | 0.014 | 0.966 (0.551~1.694) | 0.904 |
| IRA-LCX | −0.063 | 0.489 | 0.016 | 0.939 (0.360~2.450) | 0.898 |
| IRA-RCA | 0.079 | 0.291 | 0.074 | 1.082 (0.612~1.915) | 0.786 |
| BMI – body mass index; NOAF – new-onset atrial fibrillation; IABP – intra-aortic balloon pump; HGB – hemoglobin; TC – total cholesterol; TG v triglyceride; eGFR – estimated glomerular filtration rate; LVEF – left ventricular ejection fraction; HDL-C – high-density leptin cholesterol; LDL-C – low-density leptin cholesterol; CRP – C-reactive protein; WBC – white blood cell; FBG – fasting blood glucose; SBP – systolic blood pressure; DBP – diastolic blood pressure; LAD – left atrial diameter; LCX – left circumflex artery; RCA – right coronary artery; IRA – infarct-related artery; CRP – C-reactive protein; TnI – troponin I; NT-proBNP – N-terminal pro-B-type natriuretic peptide; NOAF – new-onset atrial fibrillation; PLR – platelet-to-lymphocyte ratio. | |||||